BrightSpring Health Services, Inc. (BTSGU) Cash & Equivalents (2023 - 2026)

BrightSpring Health Services has reported Cash & Equivalents for 4 years, with the latest figure at $550.4 million in Q2 2026.

• Cash & Equivalents for Q2 2026 came in at $550.4 million, up 685.47% year-over-year; the trailing twelve-month figure through Jun 2026 was $550.4 million (up 685.47% YoY), and the FY2025 annual result was $88.4 million, up 44.98% from the prior year.
• Cash & Equivalents fell to $550.4 million in Q2 2026, from $888.8 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $888.8 million in Q1 2026 and troughed at $13.1 million in Q4 2023.
• A 4-year average of $180.3 million and a median of $61.0 million in 2024 frame the typical range for Cash & Equivalents.
• The widest annual swing landed in 2025, when Cash & Equivalents fell 9.82%; it then surged 1598.22% in 2026.
• A 4-year view of Cash & Equivalents shows it stood at $13.1 million in 2023, then surged by 366.33% to $61.0 million in 2024, then soared by 44.98% to $88.4 million in 2025, then jumped by 522.81% to $550.4 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $550.4 million in Q2 2026, $888.8 million in Q1 2026, and $88.4 million in Q4 2025.